In the latest study from the Gan Lab, published in Molecular Neurodegeneration, Parra Bravo, Krukowski, and Barker et al. report two newly-generated anti-acetylated-tau-K174 antibodies that effectively mitigate neurobehavioral impairments and reduce pathology in PS19 mice— alone and in conjunction with traumatic brain injury (TBI).
The collaborative study was led by Celeste Parra Bravo from the Gan laboratory, Dr. Karen Krukowski from Dr. Susanna...